CSIMarket
 


Boston Scientific Corporation  (BSX)
Other Ticker:  
 
 

BSX's Net Income Growth by Quarter and Year

Boston Scientific's Net Income results by quarter and year




BSX Net Income (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 504.00 140.00 95.00
III Quarter September - 504.00 188.00 419.00
II Quarter June - 270.00 260.00 186.00
I Quarter March 493.00 314.00 110.00 341.00
FY   493.00 1,592.00 698.00 1,041.00



BSX Net Income first quarter 2024 Y/Y Growth Comment
Boston Scientific Corporation achieved in the first quarter 2024, above Company average Net Income rise of 57.01% year on year, to $ 493.00 millions.

Looking into first quarter 2024 results within Medical Equipment & Supplies industry 6 other companies have achieved higher Net Income growth. While Boston Scientific Corporation' s Net Income jump of 57.01% ranks overall at the positon no. 225 in the first quarter 2024.




BSX Net Income ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - 260 % 47.37 % -54.55 %
III Quarter September - 168.09 % -55.13 % -
II Quarter June - 3.85 % 39.78 % -
I Quarter March 57.01 % 185.45 % -67.74 % 3000 %
FY   - 128.08 % -32.95 % -

Financial Statements
Boston Scientific's first quarter 2024 Net Income $ 493.00 millions BSX's Income Statement
Boston Scientific's first quarter 2023 Net Income $ 314.00 millions Quarterly BSX's Income Statement
New: More BSX's historic Net Income Growth >>


BSX Net Income (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - 0 % -25.53 % -77.33 %
III Quarter September - 86.67 % -27.69 % 125.27 %
II Quarter June - -14.01 % 136.36 % -45.45 %
I Quarter March -2.18 % 124.29 % 15.79 % 63.16 %
FY (Year on Year)   - 128.08 % -32.95 % -




Net Income first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #7
Healthcare Sector #21
Overall #225

Net Income Y/Y Growth Statistics
High Average Low
1506.73 % -14.91 % -1022.68 %
(Dec 31 2018)   (Dec. 30, 2012)
Net Income first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #7
Healthcare Sector #21
Overall #225
Net Income Y/Y Growth Statistics
High Average Low
1506.73 % -14.91 % -1022.68 %
(Dec 31 2018)   (Dec. 30, 2012)

Net Income by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Boston Scientific's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
3071.43 % 102.5 % -99.72 %
(Dec 31 2019)  


BSX's I. Quarter Q/Q Net Income Comment
In the I. Quarter 2024 Boston Scientific Corporation realized fall in Net Income from the fourth quarter by -2.18% to $ 493.00 millions, from $ 504.00 millions released in the previous quarter.

Even cyclical factors were not able to rescue the I. Quarter for the Boston Scientific Corporation, Jack  N. Walker, Healthcare sector observer based in Edinburgh wrote, he cited some pessimism towards Boston Scientific's perspective.

Within Medical Equipment & Supplies industry 7 other companies have achieved higher Net Income quarter on quarter growth. While Boston Scientific's Net Income growth quarter on quarter, overall rank is 398.


Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #25
Overall #398
Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #25
Overall #398
Net Income Q/Q Growth Statistics
High Average Low
3071.43 % 102.5 % -99.72 %
(Dec 31 2019)  


BSX's I. Quarter Q/Q Net Income Comment
In the I. Quarter 2024 Boston Scientific Corporation realized fall in Net Income from the previous quarter by -2.18% to $ 493.00 millions, from $ 504.00 millions released in the previous reporting period.

Even seasonal factors which commonly energize I. Quarter 2024 Net Income, that simply has not been sufficient to rescue BSX's I. Quarter 2024 achievement, Jack  N. Walker, Healthcare sector observer based in Edinburgh wrote.

Within Medical Equipment & Supplies industry 7 other companies have achieved higher Net Income quarter on quarter growth. While Boston Scientific's Net Income growth quarter on quarter, overall rank is 398.


Boston Scientific's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
Cumulative Net Income 12 Months Ending $ 1,771.00 $ 1,592.00 $ 1,228.00 $ 912.00 $ 902.00
Y / Y Net Income Growth (TTM) 96.34 % 128.08 % 88.06 % 3.17 % 11.36 %
Year on Year Net Income Growth Overall Ranking # 357 # 593 # 726 # 190 # 66
Seqeuential Net Income Change (TTM) 11.24 % 29.64 % 34.65 % 1.11 % 29.23 %
Seq. Net Income Growth (TTM) Overall Ranking # 225 # 340 # 650 # 433 # 852




Cumulative Net Income growth Comment
Assuming the Boston Scientific's fiscal year would have ended in Mar 31 2024, Boston Scientific would have reprted above average annual Net Income growth of 96.34% year on year, of $ 1,771 millions.
This marks a slow-down of the companys growth trends and from the 128.08% surge in Dec 31 2023.

Within the Healthcare sector 29 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 357, from total ranking in previous quarter at 593.

Net Income TTM Q/Q Growth Statistics
High Average Low
1506.73 %
-14.91 %
-1022.68 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 7
Healthcare Sector # 30
Overall # 357

Net Income TTM Y/Y Growth Statistics
High Average Low
1506.73 %
-14.91 %
-1022.68 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 7
Sector # 21
S&P 500 # 225
Cumulative Net Income growth Comment
Assuming the Boston Scientific's fiscal year would have ended in Mar 31 2024, Boston Scientific would have reprted above average annual Net Income growth of 96.34% year on year, of $ 1,771 millions.
This marks a slow-down of the companys growth trends and from the 128.08% surge in Dec 31 2023.

Within the Healthcare sector 29 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 357, from total ranking in previous quarter at 593.

Net Income TTM Q/Q Growth Statistics
High Average Low
1506.73 %
-14.91 %
-1022.68 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 7
Healthcare Sector # 30
Overall # 357

Net Income TTM Y/Y Growth Statistics
High Average Low
1506.73 %
-14.91 %
-1022.68 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 7
Sector # 21
S&P 500 # 225




Other Net Income Growth
Medical Equipment & Supplies Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
BSX's Net Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for BSX's Competitors
Net Income Growth for Boston Scientific's Suppliers
Net Income Growth for BSX's Customers

You may also want to know
BSX's Annual Growth Rates BSX's Profitability Ratios BSX's Asset Turnover Ratio BSX's Dividend Growth
BSX's Roe BSX's Valuation Ratios BSX's Financial Strength Ratios BSX's Dividend Payout Ratio
BSX's Roa BSX's Inventory Turnover Ratio BSX's Growth Rates BSX's Dividend Comparisons



Companies with similar Net Income surge for the quarter ending Mar 31 2024 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2024
Nature s Sunshine Products inc 98.72%$ 98.723 millions
Halozyme Therapeutics Inc 93.92%$ 93.924 millions
Carlisle Companies Incorporated89.09%$ 89.086 millions
Davita Inc 79.28%$ 79.284 millions
Biomarin Pharmaceutical Inc74.35%$ 74.353 millions
Corcept Therapeutics Inc74.06%$ 74.062 millions
Merck and Co Inc 68.74%$ 68.743 millions
Eli Lilly And Company66.77%$ 66.771 millions
Amphastar Pharmaceuticals Inc 65.86%$ 65.861 millions
Lemaitre Vascular Inc 63.69%$ 63.692 millions
Enzon Pharmaceuticals inc 62.44%$ 62.437 millions
Lifevantage Corp62.33%$ 62.329 millions
Vertex Pharmaceuticals Inc57.13%$ 57.131 millions
Boston Scientific Corporation57.01%$ 57.006 millions
Integer Holdings Corporation56.97%$ 56.969 millions
Intuitive Surgical Inc 51.72%$ 51.718 millions
Shockwave Medical Inc 41.46%$ 41.459 millions
Medpace Holdings Inc 40.74%$ 40.740 millions
Electromed Inc 38.88%$ 38.884 millions
Select Medical Holdings Corp37.43%$ 37.428 millions
Merit Medical Systems Inc36.41%$ 36.405 millions
Stryker Corp33.11%$ 33.108 millions
Ufp Technologies Inc 30.33%$ 30.332 millions
Harmony Biosciences Holdings inc 30.01%$ 30.012 millions
Resmed Inc 29.24%$ 29.244 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com